These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 3333776)

  • 21. A new focus of visceral leishmaniasis in the Himalayas, India.
    Raina S; Mahesh DM; Kaul R; Satindera KS; Gupta D; Sharma A; Thakur S
    J Vector Borne Dis; 2009 Dec; 46(4):303-6. PubMed ID: 19959858
    [No Abstract]   [Full Text] [Related]  

  • 22. Visceral leishmaniasis in Afghanistan.
    Leslie T; Saleheen S; Sami M; Mayan I; Mahboob N; Fiekert K; Lenglet A; Ord R; Reithinger R
    CMAJ; 2006 Aug; 175(3):245. PubMed ID: 16880443
    [No Abstract]   [Full Text] [Related]  

  • 23. The poorest of the poor: a poverty appraisal of households affected by visceral leishmaniasis in Bihar, India.
    Boelaert M; Meheus F; Sanchez A; Singh SP; Vanlerberghe V; Picado A; Meessen B; Sundar S
    Trop Med Int Health; 2009 Jun; 14(6):639-44. PubMed ID: 19392741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leishmaniasis in southern Sudan.
    World Health Forum; 1993; 14(4):435. PubMed ID: 8185803
    [No Abstract]   [Full Text] [Related]  

  • 25. Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine.
    Sangraula H; Sharma KK; Rijal S; Dwivedi S; Koirala S
    J Assoc Physicians India; 2003 Jul; 51():686-90. PubMed ID: 14621038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Visceral leishmaniasis control in India through primary health care system--a successful experiment of district level planning.
    Saxena NB; Aggarwal V; Dhillon GP; Sharma RS; Rao JS
    J Commun Dis; 1996 Jun; 28(2):122-8. PubMed ID: 8810148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries.
    Berman JD; Badaro R; Thakur CP; Wasunna KM; Behbehani K; Davidson R; Kuzoe F; Pang L; Weerasuriya K; Bryceson AD
    Bull World Health Organ; 1998; 76(1):25-32. PubMed ID: 9615494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Visceral leishmaniasis control in Thi Qar Governorate, Iraq, 2003.
    Jassim AK; Maktoof R; Ali H; Budosan B; Campbell K
    East Mediterr Health J; 2006; 12 Suppl 2():S230-7. PubMed ID: 17361695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular fingerprinting of Leishmania infantum strains following an outbreak of visceral leishmaniasis in central Israel.
    Nasereddin A; Baneth G; Schönian G; Kanaan M; Jaffe CL
    J Clin Microbiol; 2005 Dec; 43(12):6054-9. PubMed ID: 16333098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is leishmaniasis in Sri Lanka benign and be ignored?
    Karunaweera ND; Rajapaksa US
    J Vector Borne Dis; 2009 Mar; 46(1):13-7. PubMed ID: 19326703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Longitudinal seroepidemiologic study of visceral leishmaniasis in hyperendemic regions of Bihar, India.
    Gidwani K; Kumar R; Rai M; Sundar S
    Am J Trop Med Hyg; 2009 Mar; 80(3):345-6. PubMed ID: 19270279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elimination of visceral leishmaniasis in Nepal: pipe-dreams and possibilities.
    Joshi AB; Banjara MR; Pokhrel S; Jimba M; Singhasivanon P; Ashford RW
    Kathmandu Univ Med J (KUMJ); 2006; 4(4):488-96. PubMed ID: 18603960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breakthrough in the management of visceral leishmaniasis.
    Thakur BB
    J Assoc Physicians India; 2003 Jul; 51():649-51. PubMed ID: 14621030
    [No Abstract]   [Full Text] [Related]  

  • 34. Short communication: post-kala-azar dermal leishmaniasis--an appraisal.
    Ramesh V; Singh R; Salotra P
    Trop Med Int Health; 2007 Jul; 12(7):848-51. PubMed ID: 17596251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Haematological findings in relation to clinical findings of visceral Leishmaniasis in Hazara Division.
    Rai ME; Muhammad Z; Sarwar J; Qureshi AM
    J Ayub Med Coll Abbottabad; 2008; 20(3):40-3. PubMed ID: 19610513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Visceral leishmaniasis: an opportunistic infection in haematological malignancy.
    Pati HP; Kashyap R; Choudhry VP; Mohapatra M
    Haematologia (Budap); 1999; 29(4):295-300. PubMed ID: 10438069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Note on Kala-azar control programme in India.
    Sharma SN
    J Indian Med Assoc; 2008 Oct; 106(10):669-70, 672. PubMed ID: 19552102
    [No Abstract]   [Full Text] [Related]  

  • 38. Relevance of direct agglutination test in seroepidemiological survey of Kala-azar in epidemic foci of Bihar.
    Sharma MC; Bimal S; Ranjan A; Das VN; Gupta AK; Kumar N; Kar SK
    J Commun Dis; 2000 Jun; 32(2):117-22. PubMed ID: 11198396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Examination of wild animals for visceral leishmaniasis in Serakh, a focus of cutaneous leishmaniasis].
    Seledtsov II
    Med Parazitol (Mosk); 1968; 37(3):369. PubMed ID: 5752037
    [No Abstract]   [Full Text] [Related]  

  • 40. Abnormal localization of visceral leishmaniasis in Turkey.
    Aydogdu I; Dinçer SL
    Trop Doct; 1996 Apr; 26(2):88. PubMed ID: 8685981
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.